Anesiva's media center is designed to provide reporters with easy access to news about the company and its products for stories in development. If you don't find what you are looking for or need more information, please contact us.
All Releases |
|
Anesiva to Present at the 2007 Citi Global Healthcare Conference on May 23, 2007
May 16, 2007
|
8.5 KB
|
|
SOUTH SAN FRANCISCO, Calif., May 16, 2007 /PRNewswire-FirstCall via COMTEX News Network/ -- Anesiva, Inc. (Nasdaq: ANSV) announced today that John P. McLaughlin, the company's chief executive officer, will present at the 2007 Citi Global Healthcare Conference in New York City on May 23, 2007 at 1:30 p.m. EDT.
To access the live webcast or the s...
|
|
|
Anesiva Announces First Quarter 2007 Financial Results
May 8, 2007
|
14.5 KB
|
|
SOUTH SAN FRANCISCO, Calif., May 8, 2007 /PRNewswire-FirstCall via COMTEX News Network/ -- Anesiva, Inc. (Nasdaq: ANSV) today reported financial results for the first quarter ended March 31, 2007 and provided an update on clinical development progress.
"We are moving forward aggressively with expanding the development of Zingo(TM) beyond the pe...
|
|
|
Anesiva to Announce First Quarter 2007 Financial Results and Host Webcast Conference Call on May 8, 2007
May 2, 2007
|
9.0 KB
|
|
SOUTH SAN FRANCISCO, Calif., May 2, 2007 /PRNewswire-FirstCall via COMTEX News Network/ -- Anesiva, Inc. (Nasdaq: ANSV) will announce financial results for the first quarter 2007 after the markets close on Tuesday, May 8, 2007 and will hold a webcast teleconference at 4:30 p.m. EDT that day. Members of Anesiva's management team will discuss financi...
|
|
|
Anesiva to Present Additional Phase 2 Data at American Pain Society Meeting on 4975 for Treatment of Post-Surgical Pain Following Knee Replacement Surgery
May 1, 2007
|
12.2 KB
|
|
SOUTH SAN FRANCISCO, May 1, 2007 /PRNewswire-FirstCall via COMTEX News Network/ -- Anesiva, Inc. (Nasdaq: ANSV) announced today that it will present additional Phase 2 data on 4975 for the treatment of post-surgical pain associated with total knee replacement surgeries. The poster presentation will take place at the 26th Annual Scientific Meeting o...
|
|
|
Anesiva to Present at 7th Annual Fortis Biotechnology Conference on April 25, 2007
Apr 19, 2007
|
8.5 KB
|
|
SOUTH SAN FRANCISCO, Calif., April 19, 2007 /PRNewswire-FirstCall via COMTEX News Network/ -- Anesiva, Inc. (Nasdaq: ANSV) announced today that John P. McLaughlin, the company's chief executive officer, will present at the 7th Annual Fortis Biotechnology Conference in London on April 25, 2007 at 3:30 p.m. GMT.
To access the live webcast or the ...
|
|
|